Clinical trial

ART First-line Treatment Durability in Russia

NCT04253119

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2019-11-26

PhaseN/A

Study timeline

Study start (actual)2019-11-26Date precision: day

Registry last updated2024-04-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV-1-infectionunresolved

Interventions

Antiretroviral/Anti HIVDRUG

Sponsors & collaborators

MSD Pharmaceuticals LLClead sponsor

Mapped research locations

MoscowRussia1 Saint PetersburgRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04253119 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.